Sarepta Therapeutics, Inc. - Common Stock (SRPT)
CUSIP: 803607100
Q4 2013 13F Holders as of 31 Dec 2013
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 105,070,763
- Total 13F shares
- 27,451,941
- Share change
- -153,523
- Total reported value
- $560,041,785
- Put/Call ratio
- 133%
- Price per share
- $20.37
- Number of holders
- 109
- Value change
- -$5,858,315
- Number of sells
- 5
Quarterly Holders Quick Answers
What is CUSIP 803607100?
CUSIP 803607100 identifies SRPT - Sarepta Therapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 803607100:
Top shareholders of SRPT - Sarepta Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| PDT Partners, LLC |
13F
|
Company |
0.09%
|
89,651
|
$4,234,000 | — | 30 Sep 2013 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.07%
|
72,090
|
$3,405,000 | — | 30 Sep 2013 | |
| Asset Management One Co., Ltd. |
13F
|
Company |
0.01%
|
10,448
|
$490,000 | — | 30 Sep 2013 | |
| Joel Isaacson & Co., LLC |
13F
|
Company |
0%
|
2,000
|
$94,000 | — | 30 Sep 2013 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0%
|
1,705
|
$81,000 | — | 30 Sep 2013 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0%
|
266
|
$13,000 | — | 30 Sep 2013 | |
| Signator Financial Services, Inc. |
13F
|
Company |
0%
|
166
|
$8,000 | — | 30 Sep 2013 |
Institutional Holders of Sarepta Therapeutics, Inc. - Common Stock (SRPT) as of Q4 2013
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2013 vs Q3 2013 Across Filers
| Investor | Q3 2013 Shares | Q4 2013 Shares | Share Diff | Share Chg % | Q3 2013 Value $ | Q4 2013 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.